MP-RM-1

• Target :

  PI3K|||EGFR|||Akt

• Related Pathways :

  PI3K/Akt/mTOR signaling|||JAK/STAT signaling|||Tyrosine Kinase/Adaptors|||Cytoskeletal Signaling|||Angiogenesis

• Bioactivity :

  MP-RM-1 is a selective murine monoclonal antibody inhibitor that targets the human epidermal growth factor receptor 3 (ErbB-3) . It blocks ErbB-3 activation induced by neuregulin 1 (NRG-1?), facilitates ErbB-3 internalization and degradation, and inhibits downstream signaling pathways like PI3K-Akt. MP-RM-1 shows potential for research on ErbB-3-overexpressing solid tumors such as breast cancer, melanoma, and prostate cancer.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C